8-KEarnings & ResultsExhibits & Filings

DANAHER CORP /DE/ 8-K Report, Financial Results (Jan 13, 2015)

Filed January 13, 2015For Securities:DHR

Summary

Danaher Corporation (DHR) filed an 8-K on January 13, 2015, to furnish a presentation made at the J.P. Morgan Healthcare Conference. This presentation provided anticipated financial performance for the full year 2014. Investors can find details about the company's expected results for the past year within this furnished document. While this filing itself does not contain a comprehensive financial statement or specific new guidance beyond what was presented, it serves as an official record of Danaher's forward-looking statements regarding its 2014 performance made at a significant industry conference. Investors should refer to the referenced presentation (Exhibit 99.1) for the specific financial insights and performance metrics discussed.

Key Highlights

  • 1Danaher Corporation filed an 8-K on January 13, 2015.
  • 2The filing is related to a presentation at the J.P. Morgan Healthcare Conference on January 13, 2015.
  • 3The presentation furnished via this 8-K discusses Danaher's anticipated financial performance for the full year 2014.
  • 4This information was provided in advance of the webcast presentation.
  • 5The presentation is incorporated by reference as Exhibit 99.1 to the 8-K.
  • 6The furnished information is not considered 'filed' for Section 18 purposes, but may be incorporated by reference in future filings.
  • 7The report is from Danaher Corporation, incorporated in Delaware, with its principal executive offices in Washington, D.C.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially furnish a presentation that Danaher Corporation made at the J.P. Morgan Healthcare Conference on January 13, 2015. This presentation contained information regarding Danaher's anticipated financial performance for the full year 2014.

The detailed financial performance information is contained within the presentation furnished as Exhibit 99.1 to this 8-K. Investors should refer to that specific exhibit for the anticipated 2014 financial results and any related commentary.

This specific 8-K filing primarily focuses on furnishing anticipated financial performance for the full year 2014. It does not appear to provide new or updated financial guidance for future periods beyond what was discussed in the J.P. Morgan Healthcare Conference presentation.

According to the filing, the information furnished is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. However, it may be incorporated by reference into future filings under the Securities Act of 1933 or the Exchange Act if expressly stated.